# GPT 5.2 Review - Reviewer 1/2 (Parallel)

**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** medium
**Timestamp:** 2026-01-23T17:45:19.419323
**Review mode:** Parallel (2 independent reviewers)
**Response ID:** resp_0f22d74a593acbb5006973a4d60bb08194a1cd8af16638c7ae
**Tokens:** 14163 in / 5875 out
**Response SHA256:** 86f7937ce05db1d5

---

## Referee Report: “Does Losing Parental Health Insurance at Age 26 Shift Births to Medicaid? A Regression Discontinuity Analysis” (January 2026)

### Summary
The paper asks an important policy question: whether the ACA dependent-coverage “aging out” at age 26 causes births to shift from private payment to Medicaid. Using the CDC Natality public-use microdata, the paper reports a discrete jump at age 26: +2.7pp Medicaid-paid births and −3.1pp private-paid births, concentrated among unmarried mothers, with no detectable changes in birth outcomes.

The topic is high-stakes and the administrative “universe” natality data are attractive. However, as currently executed, the RD design is not credible enough for a top general-interest journal. The central problem is that the running variable is effectively *discrete in integer years with very few support points* (ages 22–30), so the analysis is extremely sensitive to functional form and curvature—and the paper’s own placebo results show precisely that sensitivity. Additionally, the institutional cutoff is not as sharp as modeled (many plans end coverage at end-of-month/end-of-year), which makes the design fuzzy; with age measured coarsely, misclassification is substantial. These issues are not “robustness” details; they go to identification and inference.

Below I provide a detailed and demanding set of comments.

---

# 1. FORMAT CHECK

### Length
- The PDF shows page numbers through **p. 25**, but that includes references and appendix material. The **main text appears to end around p. 20**, with references on pp. 21–23 and appendices on pp. 24–25.
- For AER/QJE/JPE/ReStud/Ecta/AEJ:Policy standards, this is **short for a standalone empirical paper** once one excludes references/appendix. The paper would likely need **substantially more**: richer institutional detail, stronger identification validation, additional analyses, and clearer positioning vs. the existing fertility/insurance literature.

### References
- The bibliography includes some relevant ACA dependent-coverage papers and some RD staples, but **key RD methodology citations are missing** (details in Section 4 below).
- Several citations appear **duplicative or inconsistent** (e.g., Sommers et al. appears twice with the same title/year inconsistencies; Depew & Bailey reference seems mismatched to the title stated).

### Prose (bullets vs paragraphs)
- Most major sections are written in paragraphs (Intro, Related Literature, Results, Discussion).
- However, **Institutional Background** uses long numbered lists (pp. 3–4). Bullets are fine for enumerating insurance options, but in a top journal the institutional section should also include **paragraph-form argumentation** about plan rules (end-of-month coverage, special enrollment timing, retroactive Medicaid, etc.), because those details affect identification.

### Section depth (3+ substantive paragraphs each)
- **Conceptual Framework (Section 4)** is very thin (roughly one short block plus two equations). It does not meet the “3 substantive paragraphs” bar.
- **Data (Section 5)** is also relatively thin for a paper that relies critically on measurement of age and payer source.

### Figures
- Figures shown have labeled axes and visible data.
- **Internal inconsistency**: Figure 1 notes “Data: 2016–2023” while the text repeatedly says the analysis is **2023 only** (e.g., Abstract; Section 5). This must be corrected and explained.

### Tables
- Main tables report numbers; however:
  - Appendix text contains **placeholders (“Table ??”)** (Appendix A.1 and A.2). This is not acceptable for submission.
  - Table formatting is closer to a working paper than a top-journal submission (needs consistent notes, variable definitions, and replication of key specs).

**Bottom line on format:** fixable, but the paper is not yet at top-journal polish or completeness.

---

# 2. STATISTICAL METHODOLOGY (CRITICAL)

I apply your pass/fail criteria.

### (a) Standard errors
- **PASS mechanically**: Table 2 reports SEs; heterogeneity tables report SEs.

### (b) Significance testing
- **PASS mechanically**: p-values and stars are shown.

### (c) Confidence intervals
- **PASS mechanically**: Table 2 reports 95% CIs.

### (d) Sample sizes
- **PARTIAL PASS**: Table 2 reports N; heterogeneity table reports N. But additional robustness/alternative specs should also report N systematically.

### (e) DiD with staggered adoption
- Not applicable (no DiD).

### (f) RDD requirements (bandwidth + McCrary)
- **FAIL as currently executed**, for two reasons:

1) **No formal manipulation test appropriate for the setting.**  
   The paper provides a histogram (Figure 2) and calls it a “density test,” but does **not** implement a McCrary-style test (McCrary 2008) or an appropriate density discontinuity test. In discrete-running-variable settings, standard density tests need adaptation; at minimum, you need a clear, formal test strategy and a discussion of power with mass points.

2) **Inference and identification in RD with few mass points are not handled adequately.**  
   You acknowledge the discrete running variable issue (citing Kolesár & Rothe 2018), but the main estimation still relies on a parametric piecewise-linear model over ages 22–30 (9 support points) with “robust SE.” With so few support points, conventional heteroskedasticity-robust SEs are not the central issue; **specification error / curvature bias is**. Your own placebo cutoffs show large “effects,” implying the design is picking up curvature rather than a treatment-induced jump (see Section 8.3 / Table 4 / Figure 4).

**Conclusion on methodology:** Despite reporting SEs/p-values/CIs, the RD *implementation* (given the discrete running variable and weak validation) is not publishable in a top journal without major redesign.

---

# 3. IDENTIFICATION STRATEGY

### Is identification credible?
Not yet.

1) **Running variable discreteness is a first-order threat.**  
   Using age-in-years gives at most 9 bins in the main bandwidth (22–30). RD credibility typically comes from comparing observations arbitrarily close to the cutoff; you cannot do that here. The analysis becomes “functional-form-driven” rather than locally nonparametric.

2) **The policy cutoff is not a sharp cutoff in coverage at the date level.**  
   Many plans terminate dependent coverage **at the end of the month** in which the child turns 26, and some at end of year. That implies the “treatment” is **fuzzy in time** even with exact age. With age measured only in integer years, treatment assignment is severely mismeasured.

3) **Selection into giving birth at 25 vs 26 is plausible and partially evident.**  
   The paper argues women cannot time births precisely (Section 6.4), but:
   - People can and do plan pregnancies within a several-month window, and insurance incentives could shift timing at the margin.
   - More importantly, your **covariate balance test shows a statistically significant jump in college degree at 26** (Table 3). That is a red flag for local comparability in the *birth sample*.

4) **Placebos strongly undermine the RD.**  
   Section 8.3 / Table 4 shows “effects” at other cutoffs, including a very large negative jump at age 27. The paper interprets these as curvature, but this is precisely the point: with discrete support, you cannot reliably separate curvature from a true discontinuity using ad hoc polynomials.

### Are key assumptions discussed?
- Continuity is stated (Eq. 3) and some threats are discussed, but the discussion understates:
  - fuzziness of the cutoff (plan rules),
  - discrete-running-variable identification limits,
  - and selection into childbirth around 26.

### Are placebo tests and robustness checks adequate?
- You include placebo cutoffs and bandwidth sensitivity, but the placebo results **should prompt a redesign**, not be waved away.
- You do not provide the most persuasive placebo: **pre-ACA natality cohorts**. If the design is valid, there should be **no upward jump at 26** in Medicaid-paid births before dependent coverage existed (or the jump should differ sharply pre/post).

### Do conclusions follow from evidence?
- The claim “crossing 26 causes a 2.7pp increase” is too strong given the above. At best, the current evidence is suggestive of a discrete change in payer composition around age 26, but causality is not established to top-journal standards.

### Are limitations discussed?
- You mention discrete running variable and payer-at-delivery limitations. But the limitations section should be much more explicit that **the RD may not be identified** with the public-use age measure.

---

# 4. LITERATURE (MISSING REFERENCES + BibTeX)

The literature review needs to (i) cite foundational RD papers, (ii) cite modern RD practice (bias correction, bandwidth selection), (iii) cite RD with discrete running variables and local randomization, and (iv) position the contribution relative to fertility/insurance timing work.

## Key missing RD methodology citations

### Hahn, Todd & van der Klaauw (identification)
```bibtex
@article{Hahn2001,
  author  = {Hahn, Jinyong and Todd, Petra and van der Klaauw, Wilbert},
  title   = {Identification and Estimation of Treatment Effects with a Regression-Discontinuity Design},
  journal = {Econometrica},
  year    = {2001},
  volume  = {69},
  number  = {1},
  pages   = {201--209}
}
```

### Imbens & Lemieux (canonical applied RD guidance)
```bibtex
@article{ImbensLemieux2008,
  author  = {Imbens, Guido W. and Lemieux, Thomas},
  title   = {Regression Discontinuity Designs: A Guide to Practice},
  journal = {Journal of Econometrics},
  year    = {2008},
  volume  = {142},
  number  = {2},
  pages   = {615--635}
}
```

### Lee & Lemieux (comprehensive review)
```bibtex
@article{LeeLemieux2010,
  author  = {Lee, David S. and Lemieux, Thomas},
  title   = {Regression Discontinuity Designs in Economics},
  journal = {Journal of Economic Literature},
  year    = {2010},
  volume  = {48},
  number  = {2},
  pages   = {281--355}
}
```

### McCrary (density test)
```bibtex
@article{McCrary2008,
  author  = {McCrary, Justin},
  title   = {Manipulation of the Running Variable in the Regression Discontinuity Design: A Density Test},
  journal = {Journal of Econometrics},
  year    = {2008},
  volume  = {142},
  number  = {2},
  pages   = {698--714}
}
```

### Calonico, Cattaneo & Titiunik (bias-corrected inference)
```bibtex
@article{CalonicoCattaneoTitiunik2014,
  author  = {Calonico, Sebastian and Cattaneo, Matias D. and Titiunik, Rocio},
  title   = {Robust Nonparametric Confidence Intervals for Regression-Discontinuity Designs},
  journal = {Econometrica},
  year    = {2014},
  volume  = {82},
  number  = {6},
  pages   = {2295--2326}
}
```

### Gelman & Imbens (warning on high-order polynomials)
```bibtex
@article{GelmanImbens2019,
  author  = {Gelman, Andrew and Imbens, Guido},
  title   = {Why High-Order Polynomials Should Not Be Used in Regression Discontinuity Designs},
  journal = {Journal of Business \& Economic Statistics},
  year    = {2019},
  volume  = {37},
  number  = {3},
  pages   = {447--456}
}
```

## Local randomization RD (you cite one; you should add the broader framework)
```bibtex
@article{CattaneoTitiunikVazquezBare2017,
  author  = {Cattaneo, Matias D. and Titiunik, Rocio and Vazquez-Bare, Gonzalo},
  title   = {Comparing Inference Approaches for RD Designs: A Reexamination of the Effect of Head Start on Child Mortality},
  journal = {Journal of Policy Analysis and Management},
  year    = {2017},
  volume  = {36},
  number  = {3},
  pages   = {643--681}
}
```

## Domain literature gaps
You cite Daw & Sommers (2018) but should more clearly reconcile your results with theirs (they find shifts *toward private* due to the ACA expansion of dependent coverage). Also, you need to engage more with:
- measurement validity of payer on birth certificates vs insurance at conception/prenatal period;
- retroactive Medicaid enrollment around delivery.

(There is also a broader maternal insurance continuity literature—often in health policy journals—that you should cite and discuss, even if not economics “top-5.”)

---

# 5. WRITING QUALITY (CRITICAL)

### (a) Prose vs bullets
- **Mostly pass**, but the paper reads like a polished report rather than a top-journal narrative. The conceptual framework and some institutional material are thin/list-like.

### (b) Narrative flow
- The intro has a hook (“stroke of midnight on 26th birthday,” p. 1) and is readable.
- However, the narrative does not confront the biggest threats (discrete running variable; fuzzy cutoff) until later, and even then understates them.

### (c) Sentence quality
- Generally clear, but sometimes overstated causal language given the design’s limits (“causes,” “credible quasi-experimental variation,” etc.).
- Several places feel formulaic (standard RD template) rather than tailored to the peculiarities of natality measurement.

### (d) Accessibility
- Good for an economics audience. But you should explain *why payer-at-delivery is informative but imperfect* and how retroactive Medicaid affects interpretation.

### (e) Figures/Tables
- Figures are legible, but:
  - Inconsistency in years (2023 vs 2016–2023).
  - RD plots should show binned means with **bin counts**, and ideally show **age-in-months** if you can construct it.
  - Notes should define whether “private” includes employer-sponsored, marketplace, etc., as recorded.

---

# 6. CONSTRUCTIVE SUGGESTIONS (HOW TO MAKE THIS TOP-JOURNAL)

These are not cosmetic; they are design-level changes.

## A. Fix the running variable problem (most important)
1) **Obtain/construct age in months or days** at delivery if at all possible.  
   If public-use natality lacks exact dates, pursue:
   - restricted-use natality with precise DOBs (via NCHS RDC), or
   - an alternative dataset with continuous age and payer at delivery/hospitalization (HCUP SID in some states; hospital discharge data; claims).

2) If you cannot get continuous age, you must pivot to a design that is honest about discreteness:
   - Treat it as a **local randomization / adjacent-cohort** design with transparent comparisons (25 vs 26) and strong falsification tests.
   - Use methods designed for mass points (beyond “robust SE”), and report sensitivity to all plausible functional forms in a disciplined way.

## B. Address fuzzy treatment timing and misclassification
- Document insurer rules: end-of-month vs exact birthday. This matters for defining treatment at delivery.
- Consider a **donut RD** around 26 if there are definitional ambiguities, or explicitly model as **fuzzy RD** if you can define “coverage loss” probability by age-in-month.

## C. Add a pre/post policy falsification using older natality years
Even if your main analysis uses 2023, a compelling validation is:
- Estimate the same “RD at 26” in **pre-ACA natality** (e.g., 2008–2009) and show **no jump** (or a sharply different pattern), then show the jump emerges post-2010.  
This “difference-in-discontinuities” is far more persuasive than placebo cutoffs within 2023.

## D. Reassess covariate balance and selection into childbirth
- The college-degree discontinuity at 26 is a major warning sign. You need to:
  - show balance using richer predetermined covariates;
  - show sensitivity restricting to narrower windows (e.g., 25 vs 26 only, but then you need a pre/post falsification);
  - show that birth counts/density around 26 do not change in a way consistent with fertility timing responses.

## E. Strengthen the policy and fiscal contribution
- Translate the 2.7pp shift into **number of births shifted** and **approximate Medicaid spending** (with credible cost assumptions and sensitivity).
- Distinguish between:
  - Medicaid as payer due to true insurance switching vs
  - Medicaid as payer because of retroactive enrollment at delivery.

## F. Outcomes and mechanisms
- If you keep “no health effects,” you should:
  - justify power (even with huge N, bias dominates; but for outcomes, show minimal detectable effects),
  - consider outcomes more plausibly affected by payer switching: C-section rates, induction, NICU admission proxies (if available), hospital transfer, etc.

---

# 7. OVERALL ASSESSMENT

### Key strengths
- Important and policy-relevant question with clear intuition.
- Administrative universe natality data; transparent outcome (payer at delivery).
- Heterogeneity by marital status is sensible and potentially informative.
- The paper at least *acknowledges* discrete running variable concerns (often ignored).

### Critical weaknesses (blocking)
1) **RD identification is not credible with integer-age running variable and few support points.**
2) **Placebo cutoffs show large “effects,” strongly indicating specification/curvature artifacts.**
3) **No formal manipulation/density test; “visual histogram” is insufficient.**
4) **Treatment is plausibly fuzzy and mismeasured; cutoff not truly sharp at birthday.**
5) **Internal inconsistencies (data years; placeholder tables; citation inconsistencies).**

Given these, I do not think the current version meets the bar for AEJ:Policy or a top-5 general-interest journal. The project could become publishable if redesigned around a credible running variable (age in months/days) and/or a pre/post difference-in-discontinuities validation.

DECISION: REJECT AND RESUBMIT